BLSM
BlossomHill Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.01
+9.94%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
39.8%
Return on equity
-42.2%
Return on assets
49.6%
Return on invested capital
—
Asset turnover
-$46.9M
Cash from operations
$3.79
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026